| __timestamp | Halozyme Therapeutics, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 51585000000 |
| Thursday, January 1, 2015 | 105812000 | 48538000000 |
| Friday, January 1, 2016 | 113485000 | 50205000000 |
| Sunday, January 1, 2017 | 285461000 | 51096000000 |
| Monday, January 1, 2018 | 141726000 | 54490000000 |
| Tuesday, January 1, 2019 | 150446000 | 54503000000 |
| Wednesday, January 1, 2020 | 224227000 | 54157000000 |
| Friday, January 1, 2021 | 361897000 | 55338000000 |
| Saturday, January 1, 2022 | 520812000 | 55394000000 |
| Sunday, January 1, 2023 | 636892000 | 58606000000 |
| Monday, January 1, 2024 | 855907000 | 33879000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, the financial trajectories of industry giants like Johnson & Johnson and emerging players such as Halozyme Therapeutics, Inc. offer a fascinating study. Over the past decade, from 2014 to 2023, Johnson & Johnson has consistently demonstrated robust financial health, with its gross profit peaking at approximately $58.6 billion in 2023, marking a steady growth of around 14% from 2014. In contrast, Halozyme Therapeutics, Inc. has shown a remarkable growth trajectory, with its gross profit surging by over 1,100% during the same period, reaching $637 million in 2023. This stark contrast highlights the dynamic nature of the industry, where established firms maintain steady growth, while innovative companies can experience exponential increases. As the market continues to evolve, these trends underscore the importance of strategic innovation and market adaptation.
Novo Nordisk A/S and Johnson & Johnson: A Detailed Gross Profit Analysis
Johnson & Johnson vs Amgen Inc.: A Gross Profit Performance Breakdown
Johnson & Johnson and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Johnson & Johnson or Exelixis, Inc.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends